EA035739B1 - Конденсированные бициклические гетероарильные производные с активностью ингибиторов пролилгидроксилазы - Google Patents

Конденсированные бициклические гетероарильные производные с активностью ингибиторов пролилгидроксилазы Download PDF

Info

Publication number
EA035739B1
EA035739B1 EA201792057A EA201792057A EA035739B1 EA 035739 B1 EA035739 B1 EA 035739B1 EA 201792057 A EA201792057 A EA 201792057A EA 201792057 A EA201792057 A EA 201792057A EA 035739 B1 EA035739 B1 EA 035739B1
Authority
EA
Eurasian Patent Office
Prior art keywords
triazolo
pyridin
benzonitrile
pyridine
cyano
Prior art date
Application number
EA201792057A
Other languages
English (en)
Russian (ru)
Other versions
EA201792057A1 (ru
Inventor
Салех Ахмед
Грегори Баркер
Ханна Каннинг
Ричард Давенпорт
Дэвид Харрисон
Керри Дженкинс
Дэвид Ливермор
Сузанн Райт
Наташа Кинселла
Original Assignee
Такеда Фармасьютикал Компани Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Такеда Фармасьютикал Компани Лимитед filed Critical Такеда Фармасьютикал Компани Лимитед
Publication of EA201792057A1 publication Critical patent/EA201792057A1/ru
Publication of EA035739B1 publication Critical patent/EA035739B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
EA201792057A 2015-03-18 2016-03-17 Конденсированные бициклические гетероарильные производные с активностью ингибиторов пролилгидроксилазы EA035739B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1504565.1A GB201504565D0 (en) 2015-03-18 2015-03-18 Novel compounds
PCT/JP2016/059782 WO2016148306A1 (en) 2015-03-18 2016-03-17 Fused bicyclic heteroaryl derivatives having activity as phd inhibitors

Publications (2)

Publication Number Publication Date
EA201792057A1 EA201792057A1 (ru) 2018-04-30
EA035739B1 true EA035739B1 (ru) 2020-08-03

Family

ID=53051992

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201792057A EA035739B1 (ru) 2015-03-18 2016-03-17 Конденсированные бициклические гетероарильные производные с активностью ингибиторов пролилгидроксилазы

Country Status (31)

Country Link
US (1) US10287286B2 (enExample)
EP (1) EP3271357B1 (enExample)
JP (1) JP6726681B2 (enExample)
KR (1) KR102609431B1 (enExample)
CN (1) CN107531698B (enExample)
AU (1) AU2016234209B2 (enExample)
BR (1) BR112017019653B1 (enExample)
CA (1) CA2979024C (enExample)
CL (1) CL2017002354A1 (enExample)
CO (1) CO2017009353A2 (enExample)
CR (1) CR20170468A (enExample)
DK (1) DK3271357T3 (enExample)
DO (1) DOP2017000209A (enExample)
EA (1) EA035739B1 (enExample)
EC (1) ECSP17069696A (enExample)
ES (1) ES2774052T3 (enExample)
GB (1) GB201504565D0 (enExample)
GE (2) GEAP201914608A (enExample)
HU (1) HUE047918T2 (enExample)
IL (1) IL254277B (enExample)
MX (1) MX2017011902A (enExample)
MY (1) MY194873A (enExample)
NZ (1) NZ735631A (enExample)
PE (1) PE20180656A1 (enExample)
PH (1) PH12017501699B1 (enExample)
PT (1) PT3271357T (enExample)
SG (1) SG11201707280VA (enExample)
TN (1) TN2017000384A1 (enExample)
UA (1) UA123668C2 (enExample)
WO (1) WO2016148306A1 (enExample)
ZA (1) ZA201706612B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2794779T3 (es) 2016-02-24 2020-11-19 Pfizer Derivados de pirazolo[1,5-a]pirazin-4-ilo como inhibidores de JAK
EP3668858A1 (en) 2017-08-14 2020-06-24 Pfizer Inc Pyrazolo[1,5-a]pyrazin-4-yl and related derivatives
PL3808747T3 (pl) * 2018-09-13 2025-03-17 Kissei Pharmaceutical Co., Ltd. Związek imidazopirydynonowy
CN110950806A (zh) * 2019-11-14 2020-04-03 安庆博曼生物技术有限公司 四乙基氯化铵催化嘧啶环羟基氯代制备方法
JP7504822B2 (ja) * 2020-03-12 2024-06-24 キッセイ薬品工業株式会社 イミダゾピリジノン化合物を含む医薬組成物
US11718622B2 (en) 2020-03-16 2023-08-08 Exelixis Inc. Heterocyclic adenosine receptor antagonists
WO2021213380A1 (zh) * 2020-04-20 2021-10-28 深圳市塔吉瑞生物医药有限公司 吡嗪取代的烟酰胺的固体形式及其制备和用途
MX2023004518A (es) * 2020-10-20 2023-06-19 Amgen Inc Compuestos espiro heterocíclicos y métodos de uso.
US12492178B2 (en) 2021-09-01 2025-12-09 Empathbio, Inc. Stable polymorph of R-MDMA HCl
AR127488A1 (es) 2021-10-28 2024-01-31 Insilico Medicine Ip Ltd Inhibidores de la proteína que contiene el dominio de prolil hidroxilasa (phd) y usos de los mismos
EP4447963A1 (en) * 2021-12-17 2024-10-23 Akebia Therapeutics Inc. Selective phd1 inhibitor compounds, compositions, and methods of use
US11912680B2 (en) 2021-12-28 2024-02-27 Empathbio, Inc. Nitric oxide releasing prodrugs of MDA and MDMA

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0121341A1 (en) * 1983-03-03 1984-10-10 Riker Laboratories, Incorporated Triazolo(4,3-c)pyrimidines and triazolo(1,5-c)pyrimidines substituted by nitrogen-containing heterocyclic rings
US20110077267A1 (en) * 2009-07-17 2011-03-31 Japan Tobacco Inc. Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor or erythropoietin production-inducing agent
WO2011090127A1 (ja) * 2010-01-21 2011-07-28 石原産業株式会社 トリアゾロピリジン誘導体又はその塩、それらの製造方法及びそれらを含有する有害生物防除剤
WO2014030716A1 (ja) * 2012-08-23 2014-02-27 田辺三菱製薬株式会社 ピラゾロピリミジン化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209621A (en) 1979-04-27 1980-06-24 American Cyanamid Company (Substituted-phenyl)-1,2,4-triazolo[4,3-a]-pyrimidines and (substituted-phenyl)-1,2,4-triazolo[1,5-a]pyrimidines
US4572910A (en) * 1983-03-03 1986-02-25 Riker Laboratories, Inc. Triazolo[1,5-c]pyrimidines substituted by nitrogen-containing heterocyclic rings
JP2004502691A (ja) 2000-06-30 2004-01-29 ワイス 抗癌薬としての置換トリアゾロピリミジン
JP2010065026A (ja) 2008-08-13 2010-03-25 Ishihara Sangyo Kaisha Ltd ピリジル−トリアゾロピリミジン誘導体又はその塩、並びにそれらを含有する有害生物防除剤
JP2010065024A (ja) 2008-08-14 2010-03-25 Ishihara Sangyo Kaisha Ltd トリアゾロピリミジン誘導体又はその塩を含有する有害生物防除剤

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0121341A1 (en) * 1983-03-03 1984-10-10 Riker Laboratories, Incorporated Triazolo(4,3-c)pyrimidines and triazolo(1,5-c)pyrimidines substituted by nitrogen-containing heterocyclic rings
US20110077267A1 (en) * 2009-07-17 2011-03-31 Japan Tobacco Inc. Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor or erythropoietin production-inducing agent
WO2011090127A1 (ja) * 2010-01-21 2011-07-28 石原産業株式会社 トリアゾロピリジン誘導体又はその塩、それらの製造方法及びそれらを含有する有害生物防除剤
WO2014030716A1 (ja) * 2012-08-23 2014-02-27 田辺三菱製薬株式会社 ピラゾロピリミジン化合物

Also Published As

Publication number Publication date
GEP20207095B (en) 2020-04-10
PT3271357T (pt) 2020-02-21
CN107531698A (zh) 2018-01-02
JP6726681B2 (ja) 2020-07-22
BR112017019653A2 (pt) 2018-05-15
EP3271357B1 (en) 2019-11-27
HUE047918T2 (hu) 2020-05-28
CL2017002354A1 (es) 2018-05-04
CN107531698B (zh) 2024-08-13
PE20180656A1 (es) 2018-04-17
ZA201706612B (en) 2019-01-30
JP2018512408A (ja) 2018-05-17
US10287286B2 (en) 2019-05-14
MX2017011902A (es) 2017-12-15
SG11201707280VA (en) 2017-10-30
NZ735631A (en) 2023-07-28
KR20170129874A (ko) 2017-11-27
IL254277A0 (en) 2017-10-31
ECSP17069696A (es) 2018-02-28
CO2017009353A2 (es) 2017-11-30
PH12017501699A1 (en) 2018-03-12
EA201792057A1 (ru) 2018-04-30
GEAP201914608A (en) 2019-10-10
AU2016234209B2 (en) 2020-08-27
ES2774052T3 (es) 2020-07-16
DOP2017000209A (es) 2017-10-15
CA2979024A1 (en) 2016-09-22
CR20170468A (es) 2018-04-27
CA2979024C (en) 2024-02-20
GB201504565D0 (en) 2015-05-06
EP3271357A1 (en) 2018-01-24
TN2017000384A1 (en) 2019-01-16
DK3271357T3 (da) 2020-02-17
HK1249512A1 (en) 2018-11-02
WO2016148306A1 (en) 2016-09-22
BR112017019653B1 (pt) 2023-10-03
PH12017501699B1 (en) 2023-06-30
IL254277B (en) 2020-10-29
KR102609431B1 (ko) 2023-12-04
AU2016234209A1 (en) 2017-10-12
US20180072714A1 (en) 2018-03-15
MY194873A (en) 2022-12-21
UA123668C2 (uk) 2021-05-12

Similar Documents

Publication Publication Date Title
US10287286B2 (en) Compounds
EP3717471B1 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
JP2023524018A (ja) Il-17の調節因子としてのイミダゾリダジン
KR102949762B1 (ko) Eed 및 prc2 조절제로서 마크로사이클릭 아졸로피리딘 유도체
WO2022173033A1 (ja) 4-アミノキナゾリン化合物
AU2014249192A1 (en) BET bromodomain inhibitors and therapeutic methods using the same
EA027130B1 (ru) Соединения имидазопирролидинонов
TWI799399B (zh) 吡啶并〔3,4-d〕嘧啶衍生物及其藥學上所容許之鹽
EP3209664A1 (en) Bicyclic heteroaryl amine compounds as pi3k inhibitors
ES2976515T3 (es) Compuestos y composiciones para tratar afecciones asociadas con la actividad del receptor APJ
JP7834249B2 (ja) サイクリン依存性キナーゼ(cdk2)阻害薬
WO2024178390A1 (en) Covalent modifiers of akt1 and uses thereof
WO2019224096A1 (en) Heterocondensed pyridones compounds and their use as idh inhibitors
CN115873000B (zh) 异喹啉酮类及喹唑啉酮类化合物及其组合物和用途
TWI839382B (zh) 新穎雜環芳香族醯胺衍生物及含有其之醫藥
CN115785084B (zh) 嘧啶衍生物及其在药物中的应用
HK1249512B (en) Fused bicyclic heteroaryl derivatives having activity as phd inhibitors
TW202604519A (zh) Cdk4抑制劑㖠啶化合物
JP2022533700A (ja) ピリド-ピリミジン誘導体、およびそれを有効成分として含有するpi3k関連疾患の予防または治療用の医薬組成物
HK40046970B (zh) 新型杂原子芳香族酰胺衍生物以及含有其的药剂
HK40037090B (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
EA045220B1 (ru) МОДУЛЯТОРЫ Cot И СПОСОБЫ ИХ ПРИМЕНЕНИЯ